Lion River I N.V. - Net Worth and Insider Trading
Lion River I N.V. Net Worth
The estimated net worth of Lion River I N.V. is at least $760 Million dollars as of 2024-09-19. Lion River I N.V. is the 2201 Interest of corporation controlled by you of Grand Pharmaceutical Group Ltd and owns about 179,173,959 shares of Grand Pharmaceutical Group Ltd (HKSE:00512) stock worth over $760 Million. Details can be seen in Lion River I N.V.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lion River I N.V. has not made any transactions after 2022-12-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lion River I N.V.
Lion River I N.V. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lion River I N.V. owns 1 companies in total, including Grand Pharmaceutical Group Ltd (HKSE:00512) .
Click here to see the complete history of Lion River I N.V.’s form 4 insider trades.
Insider Ownership Summary of Lion River I N.V.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:00512 | Grand Pharmaceutical Group Ltd | 2022-12-07 | 2201 Interest of corporation controlled by you |
Lion River I N.V. Latest Holdings Summary
Lion River I N.V. currently owns a total of 1 stock. Lion River I N.V. owns 179,173,959 shares of Grand Pharmaceutical Group Ltd (HKSE:00512) as of December 7, 2022, with a value of $760 Million.
Latest Holdings of Lion River I N.V.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:00512 | Grand Pharmaceutical Group Ltd | 2022-12-07 | 179,173,959 | 4.24 | 759,697,586 |
Holding Weightings of Lion River I N.V.
Lion River I N.V. Form 4 Trading Tracker
According to the SEC Form 4 filings, Lion River I N.V. has made a total of 1 transactions in Grand Pharmaceutical Group Ltd (HKSE:00512) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Grand Pharmaceutical Group Ltd is the acquisition of 1,728,000 shares on December 7, 2022, which cost Lion River I N.V. around $7 Million.
Insider Trading History of Lion River I N.V.
- 1
Lion River I N.V. Trading Performance
GuruFocus tracks the stock performance after each of Lion River I N.V.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lion River I N.V. is 4.22%. GuruFocus also compares Lion River I N.V.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Lion River I N.V. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lion River I N.V.'s insider trading performs compared to the benchmark.
Performance of Lion River I N.V.
Lion River I N.V. Ownership Network
Lion River I N.V. Owned Company Details
What does Grand Pharmaceutical Group Ltd do?
Who are the key executives at Grand Pharmaceutical Group Ltd?
Lion River I N.V. is the 2201 Interest of corporation controlled by you of Grand Pharmaceutical Group Ltd. Other key executives at Grand Pharmaceutical Group Ltd include 2101 Beneficial owner Shang Hai Yuan Da Chan Rong Tou Zi Guan Li You Xian Gong Si , 2201 Interest of corporation controlled by you Hu Kaijun , and 2101 Beneficial owner East Ocean Capital (Hong Kong) Company Limited .
Grand Pharmaceutical Group Ltd (HKSE:00512) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Grand Pharmaceutical Group Ltd (HKSE:00512) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Grand Pharmaceutical Group Ltd (HKSE:00512) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Grand Pharmaceutical Group Ltd (HKSE:00512)'s detailed insider trading history can be found in Insider Trading Tracker table.
Grand Pharmaceutical Group Ltd Insider Transactions
Lion River I N.V. Mailing Address
Above is the net worth, insider trading, and ownership report for Lion River I N.V.. Currently GuruFocus does not have mailing address information for Lion River I N.V..